Literature DB >> 17169173

Impact of duration and dose of gonadotrophins on IVF outcomes.

J Ryan Martin1, Neal G Mahutte, Aydin Arici, Denny Sakkas.   

Abstract

In order to examine whether the duration of the follicular phase and changes in daily gonadotrophin dosages impact IVF outcome, a retrospective analysis of women who underwent oocyte retrieval and fresh embryo transfer was performed. Among the parameters assessed were the number of days of gonadotrophin stimulation, changes in the daily dosage of gonadotrophins, total ampoules of gonadotrophins, embryo implantation rates, clinical pregnancy rates and ongoing pregnancy rates. The number of days of gonadotrophin stimulation, as determined by standard follicular size criteria did not appear to influence IVF outcomes. There was no significant difference in pregnancy rates between women who were stimulated for <9 days, 10-11 days or >12 days. When grouped by amount of starting daily dose of gonadotrophins there was a significant inverse relationship between gonadotrophin requirements and pregnancy rates (P=0.02). The data suggest that the success of an IVF cycle depends on the ovaries' ability to develop follicles of the appropriate size, not the speed at which the ovaries perform this function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169173     DOI: 10.1016/s1472-6483(10)60654-2

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  8 in total

1.  Prolonged gonadotropin stimulation is associated with decreased ART success.

Authors:  Meleen Chuang; Athena Zapantis; Martina Taylor; Sangita K Jindal; Genevieve S Neal-Perry; Harry J Lieman; Alex Joel Polotsky
Journal:  J Assist Reprod Genet       Date:  2010-09-07       Impact factor: 3.412

2.  The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles.

Authors:  N Purandare; G Emerson; C Kirkham; C Harrity; D Walsh; E Mocanu
Journal:  Ir J Med Sci       Date:  2016-11-07       Impact factor: 1.568

3.  Stimulation Duration in Patients with Early Oocyte Maturation Triggering Criteria Does Not Impact IVF-ICSI Outcomes.

Authors:  Sophie Stout; Yohann Dabi; Charlotte Dupont; Lise Selleret; Cyril Touboul; Nathalie Chabbert-Buffet; Emile Daraï; Emmanuelle Mathieu d'Argent; Kamila Kolanska
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

Review 4.  Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).

Authors:  Human Fatemi; Wilma Bilger; Deborah Denis; Georg Griesinger; Antonio La Marca; Salvatore Longobardi; Mary Mahony; Xiaoyan Yin; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2021-05-11       Impact factor: 5.211

5.  FSH dose is negatively correlated with number of oocytes retrieved: analysis of a data set with ~650,000 ART cycles that previously identified an inverse relationship between FSH dose and live birth rate.

Authors:  Zaramasina L Clark; Mili Thakur; Richard E Leach; James J Ireland
Journal:  J Assist Reprod Genet       Date:  2021-04-08       Impact factor: 3.357

6.  Association Between the Ratio of Ovarian Stimulation Duration to Original Follicular Phase Length and In Vitro Fertilization Outcomes: A Novel Index to Optimise Clinical Trigger Time.

Authors:  Xinyang Zhao; Xu Zhang; Shanshan Wu; Jichun Tan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-25       Impact factor: 6.055

7.  The Impact of Pituitary Blockage with GnRH Antagonist and Gonadotrophin Stimulation Length on The Outcome of ICSI Cycles in Women Older than 36 Years.

Authors:  Rosane Santana; Amanda Souza Setti; Luiz Guilherme Maldonado; Fernanda Montenegro Valente; Carla Iaconelli; Assumpto Iaconelli; Edson Borges
Journal:  Int J Fertil Steril       Date:  2014-07-08

8.  ESHRE guideline: ovarian stimulation for IVF/ICSI.

Authors:  The Eshre Guideline Group On Ovarian Stimulation; Ernesto Bosch; Simone Broer; Georg Griesinger; Michael Grynberg; Peter Humaidan; Estratios Kolibianakis; Michal Kunicki; Antonio La Marca; George Lainas; Nathalie Le Clef; Nathalie Massin; Sebastiaan Mastenbroek; Nikolaos Polyzos; Sesh Kamal Sunkara; Tanya Timeva; Mira Töyli; Janos Urbancsek; Nathalie Vermeulen; Frank Broekmans
Journal:  Hum Reprod Open       Date:  2020-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.